The Latest Breaking News from FDA

Novo Nordisk's long-term strategy for weight-loss treatments has earned praise from scientists, even as investors grow cautious about timelines, competition and near-term returns.

When you grab a pre-made sandwich or a rotisserie chicken from your local grocery store, you probably assume it’s been stored at a safe temperature. But recent food safety audits suggest that assumption might not always hold up—especially during the busiest times of day. Auditors have found that temperature logs,…

Botanic Tonics’ supplement drinks have taken convenience stores by storm—even as the company has battled allegations of misleading labeling.

Eating excess sugar is linked to heart disease

The treats were sold in four-pound bags

Eli Lilly has been a huge winner in the last few months of 2025. New clinical data support its outlook in 2026, with large potential catalysts on the horizon.

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

My Dad fixed his mild hearing loss with this stylish breakthrough pair of smart glasses, and it may be the best looking over-the-counter hearing aid you can buy right now.

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has emerged over the past two decades.

Abbott’s latest regulatory progress supports its durable growth narrative. Is now the right time to revisit ABT shares?

No illnesses linked to the recalled shrimp have been reported so far, the FDA said